GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Entourage Health Corp (OTCPK:ETRGF) » Definitions » Forward PE Ratio

Entourage Health (Entourage Health) Forward PE Ratio : 0.00 (As of May. 26, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Entourage Health Forward PE Ratio?

Entourage Health's Forward PE Ratio for today is 0.00.

Entourage Health's PE Ratio without NRI for today is 0.00.

Entourage Health's PE Ratio for today is 0.00.


Entourage Health Forward PE Ratio Historical Data

The historical data trend for Entourage Health's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entourage Health Forward PE Ratio Chart

Entourage Health Annual Data
Trend 2018-12 2019-12 2020-12 2021-03
Forward PE Ratio
11.81 16.26 8.75 13.99

Entourage Health Quarterly Data
2018-09 2018-12 2019-03 2019-09 2019-12 2020-03 2020-06 2020-09 2020-12 2021-03
Forward PE Ratio 28.17 11.81 22.17 8.42 16.26 8.95 5.05 3.72 8.75 13.99

Competitive Comparison of Entourage Health's Forward PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Entourage Health's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entourage Health's Forward PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Entourage Health's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Entourage Health's Forward PE Ratio falls into.



Entourage Health Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Entourage Health  (OTCPK:ETRGF) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Entourage Health Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Entourage Health's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Entourage Health (Entourage Health) Business Description

Traded in Other Exchanges
Address
250 Elm Street, Aylmer, ON, CAN, N5H 2M8
Entourage Health Corp is a licence holder producing and distributing cannabis products for both the medical and adult-use markets. It owns and operates greenhouse, outdoor, and processing facility located in Strathroy as well as a fully licensed Aylmer processing facility, specializing in cannabis extraction. With the addition of Starseed Medicinal, a medical-centric brand, it has expanded its multi-channeled distribution. The company operates in one segment, the production and sale of cannabis in Canada.